Coya Therapeutics, Inc. (COYA)

CIK 1835022 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Coya Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 11, 20268-K0001193125-26-343473
Aug 11, 202610-Q0001193125-26-343481
Aug 7, 20268-K/A0001193125-26-340449
Jul 27, 2026SCHEDULE 13G/A0001493152-26-034737
Jun 25, 20268-K0001193125-26-282989
May 13, 2026DEF 14A0001193125-26-220688
May 13, 2026DEFA14A0001193125-26-220690
May 13, 2026ARS0001193125-26-220695
May 12, 20268-K0001193125-26-218282
May 12, 202610-Q0001193125-26-218201
May 12, 2026424B50001193125-26-218278
May 12, 20268-K0001193125-26-218198
Apr 9, 202630001193125-26-149960
Apr 9, 202640001193125-26-149968
Apr 2, 20268-K0001193125-26-139094
Mar 20, 2026EFFECT9999999995-26-000895
Mar 20, 2026424B30001193125-26-117738
Mar 16, 202610-K0001193125-26-107281
Mar 16, 2026S-30001193125-26-107413
Mar 16, 20268-K0001193125-26-107276
Mar 12, 2026SCHEDULE 13G0001575872-26-000104
Jan 30, 2026SCHEDULE 13G/A0000102909-26-000083
Jan 30, 20268-K0001193125-26-030531
Jan 28, 2026SCHEDULE 13G/A0001493152-26-003978
Jan 26, 202640001193125-26-021724